Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PNP | P00491 | 1/20 | 0.62 |
| ▸ | XDH | P47989 | 3/20 | 0.59 |
| ▸ | PI4KA | P42356 | 2/20 | 0.56 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.56 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.56 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.56 |
| ▸ | CDK1 | P06493 | 1/20 | 0.55 |
| ▸ | PDE4A | P27815 | 1/20 | 0.55 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.55 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.55 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1394088 | 0.99 | PNP (0.61) | PNPXDHPI4KAPI4K2BPI4K2A | |
| Cyanide SCHEMBL2694132 | 0.96 | PNP (0.58) | PNPXDHPI4KAPI4K2BPI4K2A | |
| Hydrochloric Acid SCHEMBL17186589 | 0.91 | XDH (0.53) | PNPXDHPI4KAPI4K2BPI4K2A | |
| Piperidine SCHEMBL1938301 | 0.91 | PNP (0.53) | PNPXDHPI4KAPI4K2BPI4K2A | |
| SCHEMBL28722094 | 0.89 | PNP (0.51) | PNPXDHPI4KAPI4K2BPI4K2A | |
| SCHEMBL6812718 | 0.88 | XDH (0.57) | XDH | |
| SCHEMBL17554279 | 0.87 | XDH (0.63) | XDH | |
| SCHEMBL25269638 | 0.87 | XDH (0.56) | XDH | |
| SCHEMBL29561480 | 0.87 | XDH (0.56) | XDH | |
| SCHEMBL30101022 | 0.86 | PDE9A (0.54) | XDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6031 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746918-A1 | METHODS OF PREPARING SURFACE MODIFIED VIRAL CAPSIDS | Borea Therapeutics S.r.l. (IT) | 2026-05-27 | — | — | EP | claimed |
| WO-2026101423-A1 | PHOTOSWITCHABLE CHEMICAL INDUCED DIMERIZATION SYSTEMS FOR CONTROL OF CELLULAR ACTIVITIES WITH LIGHT | WU YAOWEN (SE) | 2026-05-15 | — | — | WO | claimed |
| US-20260130982-A1 | METHODS FOR ASSEMBLING PROTEIN-CONJUGATED NANOCARRIER VACCINES | UNIV NORTHWESTERN (US) | 2026-05-14 | — | — | US | claimed |
| EP-4740932-A2 | COSMETIC COMPOSITION FOR SKIN IMPROVEMENT AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SKIN DAMAGE, EACH CONTAINING HONOKIOL AND POLYOL | Cosmax, Inc. (KR) | 2026-05-13 | — | — | EP | claimed |
| WO-2026085618-A1 | METHOD OF IMMOBILIZING CAPTURE PROBES TO SOLID PHASES FOR TARGET SUBSTANCE DETECTION | YYZ PHARMATECH INC. (CA) | 2026-04-30 | — | — | WO | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260103737-A1 | ENZYMATIC METHODS TO GENERATE HIGH YIELDS OF SEQUENCE SPECIFIC RNA OLIGONUCLEOTIDES WITH EXTREME PRECISION | UNIV MASSACHUSETTS (US) | 2026-04-16 | — | — | US | claimed |
| EP-4716533-A2 | FLUORESCENT INDICATORS FOR METAL ION DETECTION AS SUBSTRATES FOR A SELF-LABELING ENZYME | Ion Biosciences (US) | 2026-04-01 | — | — | EP | claimed |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | claimed |
| EP-3336099-B1 | METHOD FOR SELECTIVELY BINDING CELLS TO A BINDING PARTNER AND DEVICE COMPRISING CELLS | KARLSRUHER INST TECHNOLOGIE (DE) | 2026-03-04 | — | — | EP | claimed |
| CN-1628852-A | Anti solid tumor medicine composition | KONG QINGZHONG (CN) | 2005-06-22 | — | — | CN | claimed |
| EP-1518854-A1 | Substituted 06- benzylguanines and 7- or 9- substituted 8-aza-06-benzylguanines | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2005-03-30 | — | — | EP | claimed |
| CN-1527941-A | By using O6Method for preparing -alkylguanine-DNA alkyltransferase | ��ɣ��̬�ۺϼ������Ϲ�˾ | 2004-09-08 | — | — | CN | claimed |
| US-20040115130-A1 | Methods using O6 -alkyguanine-dna alkyltransferases | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2004-06-17 | — | — | US | claimed |
| EP-1410023-A2 | METHODS USING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASES | Ecole Polytechnique Fédérale de Lausanne (CH) | 2004-04-21 | — | — | EP | claimed |
| WO-2002083937-A2 | METHODS USING O6-ALKYLGUANINE-DNA ALKYLTRANSFERASES | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (CH) | 2002-10-24 | — | — | WO | claimed |
| EP-1054890-A1 | OLIGODEOXYRIBONUCLEOTIDES COMPRISING O6-BENZYLGUANINE AND THEIR USE | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2000-11-29 | — | — | EP | claimed |
| WO-1999041269-A1 | OLIGODEOXYRIBONUCLEOTIDES COMPRISING O6-BENZYLGUANINE AND THEIR USE | THE UNITED STATES OF AMERICA, REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-08-19 | — | — | WO | claimed |
| EP-0775142-A1 | SUBSTITUTED O6 -BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1997-05-28 | — | — | EP | claimed |
| WO-1996004281-A1 | SUBSTITUTED O6-BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-15 | — | — | WO | claimed |